D-0494-2026 Class III Ongoing

Recalled by American Regent, Inc. — New Albany, OH

FDA drug recall D-0494-2026 was initiated by American Regent, Inc. on Apr 16, 2026 and is designated Class III. Reason for recall: Labeling: Missing Label The recall status is ongoing. Affected quantity: 74,040 Single Dose Vials.

Recall details

Product Type
Drugs
Report Date
May 6, 2026
Initiation Date
Apr 16, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
74,040 Single Dose Vials

Product description

Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01

Reason for recall

Labeling: Missing Label

Distribution pattern

U.S. Nationwide

Code information

Lot 24159N0C0, Exp. June 30, 2026 Lot 25193N0C0, Exp. July 31, 2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0494-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0494-2026. Report a data issue: hello@regdatalab.com.